Vergoeding 2020-2024 voor ATC-subgroep A16AX : Diverse maagdarmkanaal- en metabolismeproducten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A16AX03 Fenylboterzuur (Ammonaps ®) | 209.280 | 187.920 | 213.220 | 152.500 | 77.816 |
| A16AX04 Nitisinon (Orfadin ®) | 2.043.000 | 1.688.700 | 1.687.700 | 1.411.600 | 1.513.700 |
| A16AX05 Zinkacetaat (Wilzin ®) | 79.175 | 79.544 | 85.661 | 88.944 | 81.248 |
| A16AX06 Miglustat (Zavesca ®) | 1.478.600 | 1.280.000 | 944.730 | 746.650 | 692.780 |
| A16AX07 Sapropterine (Kuvan ®) | 6.642.700 | 6.875.200 | 7.415.200 | 6.874.800 | 5.912.300 |
| A16AX09 Glycerolfenylbutyraat (Ravicti ®) | 592.700 | 678.480 | 965.010 | 1.129.600 | 1.266.900 |
| A16AX10 Eliglustat (Cerdelga ®) | 2.186.100 | . | . | . | . |
| A16AX11 Benzoaat natrium | 83.278 | 88.264 | 80.705 | 113.400 | 113.500 |
| A16AX12 Trientine (Cuprior ®) | 519.330 | 1.529.200 | 1.671.400 | 1.596.500 | 2.015.600 |
| A16AX15 Telotristat (Xermelo ®) | 307.990 | 328.790 | 391.350 | 362.040 | 476.040 |
| A16AX16 Givosiran (Givlaari ®) | . | 288.610 | 2.218.300 | 1.975.500 | 2.715.800 |
| Totaal | 14.142.153 | 13.024.708 | 15.673.276 | 14.451.534 | 14.865.684 |